Tresiba Flex Touch Insulin Degludec Pen

Tresiba FlexTouch Insulin Degludec Pen – Ultra Long-Acting Insulin for Diabetes Management

Tresiba FlexTouch Insulin Degludec Pen contains Insulin Degludec, an ultra-long-acting basal insulin used to improve blood sugar control in adults and children with diabetes mellitus. It provides a steady and prolonged insulin release, helping maintain stable blood glucose levels throughout the day and night with a duration of action exceeding 24 hours. The FlexTouch pre-filled pen is designed for convenient and accurate insulin administration. Its easy-to-use dosing mechanism helps patients deliver the prescribed dose with confidence while supporting consistent diabetes management. Tresiba is commonly used as part of a comprehensive diabetes treatment plan that includes a balanced diet, regular physical activity, and routine blood glucose monitoring. It may be prescribed alone or in combination with other diabetes medications as directed by a healthcare professional.

Key Features

• Ultra Long-Acting Insulin: Provides continuous blood glucose control for more than 24 hours.
• Flexible Dosing Schedule: Offers flexibility in administration timing when prescribed.
• Pre-Filled FlexTouch Pen: Designed for easy and accurate dose delivery.
• Supports Stable Blood Sugar Levels: Helps reduce fluctuations in glucose levels.
• Suitable for Type 1 & Type 2 Diabetes: Used as a basal insulin therapy.

Key Ingredient

• Insulin Degludec: An ultra long-acting insulin analog that helps regulate blood glucose levels.

How to Use

• Use exactly as prescribed by your healthcare professional.
• Administer as a subcutaneous injection in the abdomen, thigh, or upper arm.
• Rotate injection sites regularly to reduce the risk of skin-related complications.
• Use a new sterile needle for each injection.
• Monitor blood glucose levels regularly as advised by your doctor.
• Do not change the dose without medical guidance.

Precautions

• Use only under medical supervision.
• Do not share the pen device with other individuals.
• Store unopened pens in a refrigerator at 2°C–8°C.
• Do not freeze or expose the insulin to excessive heat.
• Inform your healthcare provider about any kidney, liver, or heart conditions.

Warning

• May cause hypoglycemia (low blood sugar), which can be serious if untreated.
• Common side effects may include injection site reactions, swelling, itching, or weight gain.
• Seek immediate medical attention if severe allergic reactions occur.
• Keep out of reach of children.

Legal Disclaimer: Tresiba FlexTouch Insulin Degludec Pen is a prescription medication intended for the management of diabetes mellitus. Use only under the supervision of a qualified healthcare professional. This information is provided for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.